244
Views
0
CrossRef citations to date
0
Altmetric
Case Series

Clinical Characteristics and Image Manifestations of a Rare Retinoblastoma with a Bone Metastasis

ORCID Icon, , , , , , , ORCID Icon, ORCID Icon, & show all
Pages 1565-1575 | Published online: 26 Apr 2022

References

  • Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93(9):1129–1131. doi:10.1136/bjo.2008.150292
  • Aerts I, Lumbroso-le Rouic L, Gauthier-Villars M, Brisse H, Doz F. Retinoblastoma update. Arch Pediatr. 2016;23(1):112–116. doi:10.1016/j.arcped.2015.09.025
  • Temming P, Lohmann D, Bornfeld N, Sauerwein W, Goericke SL, Eggert A. Current concepts for diagnosis and treatment of retinoblastoma in Germany: aiming for safe tumor control and vision preservation. KlinPaediatr. 2012;224(6):339–347.
  • Huang D, Zhang Y, Zhang W, et al. Study on clinical therapeutic effect including symptoms, eye preservation rate, and follow-up of 684 children with retinoblastoma. Eur J Ophthalmol. 2013;23(4):532–538. doi:10.5301/ejo.5000245
  • Gündüz K, Müftüoglu O, Günalp I, Unal E, Taçyildiz N. Metastatic retinoblastoma clinical features, treatment, and prognosis. Ophthalmology. 2006;113(9):1558–1566. doi:10.1016/j.ophtha.2006.03.039
  • Hu HM, Zhang WL, Wang YZ, et al. Clinical features, treatment and prognosis of retinoblastoma in distant metastasis stage. Zhonghua Yan KeZaZhi. 2017;53(2):121–127.
  • Dunkel IJ, Khakoo Y, Kernan NA, et al. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. Pediatr Blood Cancer. 2010;55(1):55–59. doi:10.1002/pbc.22504
  • Dunkel IJ, Chan HSL, Jubran R, et al. High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma. Pediatr Blood Cancer. 2010;55(1):149–152. doi:10.1002/pbc.22491
  • Haik BG, Dunleavy SA, Cooke C, et al. Retinoblastoma with anterior chamber extension. Ophthalmology. 1987;94(4):367–370. doi:10.1016/S0161-6420(87)33437-2
  • Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987;94(4):371–377. doi:10.1016/S0161-6420(87)33436-0
  • Shields CL, Shields JA, Baez K, Cater JR, De Potter P. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer. 1994;73(3):692–698. doi:10.1002/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8
  • Finger PT, Harbour JW, Karcioglu ZA. Risk factors for metastasis in retinoblastoma. SurvOphthalmol. 2002;47(1):1–16.
  • Baroni LV, Sampor C, Fandiño A, et al. Anterior segment invasion in retinoblastoma: is it a risk factor for extraocular relapse? J Edatrexate lOncol. 2014;36(8):e509–e512.
  • Sreelakshmi KV, Chandra A, Krishnakumar S, Natarajan V, Khetan V. Anterior Chamber invasion in retinoblastoma: not an indication for adjuvant chemotherapy. Invest Ophthalmol Vis Sci. 2017;58(11):4654–4661. doi:10.1167/iovs.17-22111
  • Zhao J, Dimaras H, Massey C, et al. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis. J ClinOncol. 2011;29(7):845–851. doi:10.1200/JCO.2010.32.5332
  • Wang YZ, Huang DS, Shi JT, et al. Effects of pre-enucleation chemotherapy on pathological stage and prognosis of patients with intraocular retinoblastoma. J China Pediatr Blood Cancer. 2016;21:269–274.
  • Choi J, Raghavan M. Diagnostic imaging and image-guided therapy of skeletal metastases. Cancer Control. 2012;19(2):102–112. doi:10.1177/107327481201900204
  • Tubiana-Hulin M. Incidence, prevalence and distribution of bone metastases. Bone. 1991;12(suppl 1):S9–S10. doi:10.1016/8756-3282(91)90059-R
  • Krishnamurthy GT, Tubis M, Hiss J, Blahd WH. Distribution pattern of metastatic bone disease. A need for total body skeletal image. JAMA. 1977;237(23):2504–2506. doi:10.1001/jama.1977.03270500056025
  • Even–Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med. 2005;46(8):1356–1367.
  • Chang CY, Gill CM, Joseph Simeone FJ, et al. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases. ActaRadiol. 2016;57(1):58–65.
  • Liu ZP, Zhou KY, Chen LL, Xiao ZH, Chen YZ. A preliminary study of retinoblastoma-related serum tumor markers. Zhongguo Dang Dai ErKeZaZhi. 2017;19(3):318–321.
  • Ting SC, Kiefer T, Ehlert K, et al. Bone metastasis of retinoblastoma five years after primary treatment. Am J Ophthalmol Case Rep. 2020;19:100834. doi:10.1016/j.ajoc.2020.100834